In summary, our study revealed a previously unknown inhibitory efficacy of celastrol on ESCC by activating DR5-dependent extrinsic and Noxa/Bim-dependent intrinsic apoptosis, suggesting that celastrol was a candidate for apoptosis inducer in recalcitrant human ESCC. This evidence concerns the gene PMAIP1 and esophageal squamous cell carcinoma.